Clinical Trial Update: A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of paliperidone in volunteers with normal or impaired liver function to assess drug exposure and safety considerations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PALIPERIDONE (paliperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Hepatic Impairment | Phase 1 | Status: COMPLETED